US Edition"Groundbreaking" Obesity Treatment That Turns Up The Heat On Fat Cells Passes Phase I Clinical Trials
URUGUAY, JUL 24 – Phase I trial of SANA showed a 3% average body weight loss in two weeks without appetite suppression, offering a novel obesity treatment activating fat cell thermogenesis.
Summary by IFLScience
2 Articles
2 Articles
World-first obesity pill reprograms fat cells to burn calories with zero effort
The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.Continue ReadingCategory: Obesity, Illnesses and conditions, Body & MindTags: Obesity, GLP-1 receptor agonists, Weight Loss, Brown fat, Beige fat, Body fat, Fat cells, Diabetes
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
